心肌病磁共振成像40年发展——更精准、更智能  

Development of MRI of cardiomyopathy in the last 40 years:More precise and intelligent

作　　者：张文博[1] 程敬亮[1] ZHANG Wenbo;CHENG Jingliang(Department of MRI,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)

机构地区：[1]郑州大学第一附属医院磁共振科,郑州450052

出　　处：《磁共振成像》2022年第12期1-5,12,共6页Chinese Journal of Magnetic Resonance Imaging

摘　　要：自从20世纪80年代我国将MRI技术应用于心肌病成像以来,心血管MRI技术的进步极大地提高了人们识别心肌病及其亚型的能力。本文首先介绍心肌病的定义及分类演变过程,然后讨论MR定量技术、影像组学和人工智能技术在各种心肌病的鉴别诊断、危险分层和预后评估中的应用价值,最后阐述新技术应用存在的机遇与挑战。未来,我们期望通过多中心、大样本的队列研究、荟萃分析及综述,建立标准的成像方法和参考标准,服务于临床诊疗过程,保障人民的健康。Since the 1980s when MRI technology was applied to the cardiomyopathy imaging in China,the ability to identify cardiomyopathies and their subtypes has been greatly enhanced by advances in cardiovascular MRI.In this article,we first introduce the classification and evolution of cardiomyopathies and then discuss the value of quantitative MRI,the use of radiomics and artificial intelligence technologies in differential diagnosis,risk stratification,and prognostic evaluation of various cardiomyopathies,and concludes by describing the opportunities and challenges of applying new technologies.We expect to establish standard imaging methods and reference values in the future through large-scale,multicenter cohort studies,meta-analyses,and reviews with large sample sizes in order to serve the clinical treatment process and protect individuals'health.

关 键 词：心肌病 定量技术 磁共振成像 影像组学 人工智能 

分 类 号：R445.2[医药卫生—影像医学与核医学] R542.2[医药卫生—诊断学]